SEELOS THERAPEUTICS, INC. (APRI) [Rocket]

In millions, except per share items	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15	Dec-31-14
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Total revenues [+]	0.0	0.0	0.4	0.0	0.0	0.0	4.8	9.3
Licensing							3.6	8.5
Royalties							0.7	0.0
Products							0.6	0.8
Revenue growth		-100.0%				-100.0%	-47.7%	268.7%
Cost of goods sold	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.9
Gross profit	0.0	0.0	0.4	0.0	0.0	0.0	3.9	8.3
Gross margin			100.0%				80.9%	90.1%
Selling, general and administrative [+]	15.0	7.8	7.6	2.6	7.2	7.8	10.5	11.4
General and administrative	15.0	7.8	7.6	2.6	7.2	7.8	10.5	11.4
Research and development	46.6	11.0	22.6	0.6	3.5	5.9	14.6	21.3
Other operating expenses			16.5		0.0	0.0	0.1	-1.0
EBITDA [+]					-10.6	-13.6	-21.1	-23.2
EBITDA growth	228.7%	-59.4%	1352.5%	-69.8%	-22.2%	-35.6%	-9.4%	29.6%
EBITDA margin			-12332.8%				-435.0%	-250.9%
Depreciation and amortization					0.1	0.1	0.3	0.2
EBIT [+]	-61.7	-18.8	-46.2	-3.2	-10.7	-13.7	-21.4	-23.4
EBIT growth	228.7%	-59.4%	1352.5%	-70.2%	-21.9%	-36.0%	-8.8%	30.0%
EBIT margin			-12332.8%				-441.2%	-252.8%
Non-recurring items			-16.5					-0.8
Interest expense	1.6	0.2	0.0	0.1	0.1	1.0	0.9	0.3
Interest expense	1.6	0.2	0.0	0.1	0.1	1.0	0.9	0.3
Other income (expense), net [+]	-2.8	-0.2	-21.5	-0.2	-1.0	7.0	3.2	0.4
Gain (loss) on debt retirement	0.1				-0.4			-0.1
Change in fair value of warrants			-16.5		-0.6	7.5	3.2
Other	-0.5	-0.2			0.1	0.0	0.0	0.5
Pre-tax income	-66.0	-19.1	-51.3	-3.5	-11.7	-7.7	-19.0	-22.5
Income taxes	0.0	0.0	0.0	0.0	-12.1	-0.2	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	102.7%	3.0%	0.0%	0.0%
Earnings from continuing ops	-66.0	-19.1	-51.3	-3.5	-11.7	-7.7	-19.0	-22.5
Earnings from discontinued ops								0.7
Net income	-66.0	-19.1	-51.3	-3.5	0.3	-7.4	-19.0	-21.8
Net margin			-13668.0%				-393.1%	-235.3%

Basic EPS [+]	($0.73)	($0.43)	($2.52)	($1.13)	($29.67)	($1.18)	($3.83)	($0.57)
Growth	70.3%	-83.1%	123.8%	-96.2%	2424.5%	-69.3%	572.9%	23.3%
Diluted EPS [+]	($0.73)	($0.43)	($2.52)	($1.13)	($29.67)	($1.18)	($3.83)	($0.57)
Growth	70.3%	-83.1%	123.8%	-96.2%	2424.5%	-69.3%	572.9%	23.3%

Shares outstanding (basic) [+]	90.9	44.8	20.3	3.1	0.4	6.5	5.0	39.5
Growth	103.0%	120.4%	559.0%	678.2%	-93.9%	31.1%	-87.4%	14.9%
Shares outstanding (diluted) [+]	90.9	44.8	20.3	3.1	0.4	6.5	5.0	39.5
Growth	103.0%	120.4%	559.0%	678.2%	-93.9%	31.1%	-87.4%	14.9%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.